Related Experiment Video
Updated: Dec 20, 2025

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
ROCK-mediated selective activation of PERK signalling causes fibroblast reprogramming and tumour progression through
Sarah Theresa Boyle1, Valentina Poltavets1, Jasreen Kular1
1Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.
Abstract:
It is well accepted that cancers co-opt the microenvironment for their growth. However, the molecular mechanisms that underlie cancer-microenvironment interactions are still poorly defined. Here, we show that Rho-associated kinase (ROCK) in the mammary tumour epithelium selectively actuates protein-kinase-R-like endoplasmic reticulum kinase (PERK), causing the recruitment and persistent education of tumour-promoting cancer-associated fibroblasts (CAFs), which are part of the cancer microenvironment. An analysis of tumours from patients and mice reveals that cysteine-rich with EGF-like domains 2 (CRELD2) is the paracrine factor that underlies PERK-mediated CAF education downstream of ROCK. We find that CRELD2 is regulated by PERK-regulated ATF4, and depleting CRELD2 suppressed tumour progression, demonstrating that the paracrine ROCK-PERK-ATF4-CRELD2 axis promotes the progression of breast cancer, with implications for cancer therapy.
Insights
Breast cancer growth is fueled by a pathway involving Rho-associated kinase (ROCK) and protein-kinase-R-like endoplasmic reticulum kinase (PERK). This axis educates cancer-associated fibroblasts (CAFs), promoting tumor progression and offering new therapeutic targets.
Area of Science:
- Oncology
- Cell Biology
- Cancer Microenvironment Research
Background:
- Cancers extensively utilize their microenvironment to facilitate tumor growth.
- The precise molecular mechanisms governing cancer-microenvironment interactions remain incompletely understood.
- Identifying these mechanisms is crucial for developing effective cancer therapies.
Purpose of the Study:
- To elucidate the molecular mechanisms by which mammary tumor epithelium interacts with and educates cancer-associated fibroblasts (CAFs).
- To identify key signaling pathways and factors involved in cancer-microenvironment crosstalk.
- To explore the therapeutic potential of targeting identified pathways in breast cancer.
Main Methods:
- Investigated the role of Rho-associated kinase (ROCK) in mammary tumor cells.
- Analyzed the activation of protein-kinase-R-like endoplasmic reticulum kinase (PERK) downstream of ROCK.
- Identified cysteine-rich with EGF-like domains 2 (CRELD2) as a key paracrine factor using patient and mouse tumor samples.
- Examined the regulation of CRELD2 by ATF4 and the impact of CRELD2 depletion on tumor progression.
Main Results:
- ROCK in the mammary tumor epithelium activates PERK.
- Activated PERK leads to the recruitment and education of tumor-promoting CAFs.
- CRELD2 is identified as the paracrine mediator of PERK-driven CAF education.
- The ROCK-PERK-ATF4-CRELD2 signaling axis was found to drive breast cancer progression.
Conclusions:
- The paracrine axis involving ROCK, PERK, ATF4, and CRELD2 plays a significant role in promoting breast cancer progression.
- Targeting this axis could represent a novel therapeutic strategy for breast cancer.
- Understanding these molecular interactions is vital for advancing cancer treatment.
More Related Videos
09:52A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
Published on: September 20, 2016
06:35A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway
Abnormal Proliferation
MAPK Signaling Cascades